The impact of eosinophil levels on current prescribing in COPD

L. Flint (Leeds, United Kingdom), D. Dimov (Leeds, United Kingdom)

Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session: COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session type: E-poster session
Number: 3251
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Flint (Leeds, United Kingdom), D. Dimov (Leeds, United Kingdom). The impact of eosinophil levels on current prescribing in COPD. 3251

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: